Laboratory Testing for Liver Function in Moderate Alcohol Drinkers
For patients consuming moderate alcohol (≤1 drink/day for women, ≤2 drinks/day for men), obtain baseline liver enzymes including ALT, AST, and GGT, along with a complete metabolic panel to assess for early hepatic injury, even though this level of consumption carries relatively low risk for alcohol-related liver disease. 1
Initial Laboratory Panel
The following tests should be ordered for baseline assessment:
- Alanine aminotransferase (ALT)
- Aspartate aminotransferase (AST)
- Gamma-glutamyltransferase (GGT)
- Alkaline phosphatase (ALP)
- Total and direct bilirubin
- Complete blood count (CBC) - to assess mean corpuscular volume (MCV) and platelet count
- INR/PT - to evaluate synthetic liver function
- Total protein, albumin, and globulin
Understanding Risk Context
While moderate drinking is defined as ≤14 g/day (1 drink) for women and ≤28 g/day (2 drinks) for men, the relationship between alcohol and liver disease is exponential. At 20 units/week (~140 g/week), relative risk for cirrhosis is approximately 3-fold, escalating to 30-fold at 80 units/week 1. Importantly, 25% of the population drinks more than recommended guidelines, making objective assessment critical since alcohol consumption is frequently underreported 2.
Interpreting Results in Moderate Drinkers
Pattern Recognition
- AST/ALT ratio <1: More suggestive of non-alcoholic fatty liver disease (MASLD), particularly if metabolic risk factors present 3
- AST/ALT ratio >2: Highly suggestive of alcohol-related liver disease, even at moderate consumption levels 4, 5
- Isolated GGT elevation: Shows dose-dependent correlation with alcohol intake; approximately 75% of patients drinking >60 g/day for ≥5 weeks show elevated GGT 4
- Elevated MCV: Dose-dependent marker of excessive alcohol intake 4
Critical Thresholds
Even at moderate consumption levels, certain populations show increased risk:
- Age >40 years: Lower threshold for liver enzyme abnormalities 6
- BMI >25 or metabolic syndrome: Synergistic effect doubles liver disease risk at any given alcohol intake 1
- Women: Threshold for significant GGT elevation is 7 standard weekly drinks vs. 14 for men 6
When to Escalate Assessment
If initial liver enzymes are abnormal, proceed with:
Extended liver etiology screen including:
- Hepatitis B surface antigen and hepatitis C antibody
- Autoimmune markers (ANA, ASMA, immunoglobulins)
- Iron studies (ferritin, transferrin saturation)
- Ceruloplasmin (if age <40)
Fibrosis assessment using FIB-4 score (calculated from ALT, AST, platelet count, and age):
Abdominal ultrasound to assess for steatosis and exclude structural abnormalities 1
Monitoring Strategy
For moderate drinkers with normal baseline tests:
- Repeat testing is not routinely required unless clinical circumstances change (weight gain, increased consumption, new symptoms)
For moderate drinkers with mildly elevated enzymes (ALT/AST 2-4× normal):
- Repeat testing in 3-6 months
- Address metabolic risk factors aggressively
- Consider alcohol biomarkers if consumption history uncertain 2, 4
Common Pitfalls to Avoid
Assuming normal liver tests exclude liver disease: Normal ALT/AST do not rule out advanced fibrosis or cirrhosis, particularly in chronic alcohol use 1
Relying solely on patient-reported alcohol intake: Use validated screening tools like AUDIT-C or objective biomarkers (phosphatidylethanol, ethyl glucuronide) when history is uncertain 2, 4
Ignoring synergistic risk factors: The combination of even moderate alcohol with obesity (BMI >35) doubles liver disease risk 1
Missing the window for intervention: GGT and CDT normalize within 2-3 weeks of abstinence, potentially masking recent heavy consumption 4
Referral Indications
Refer to hepatology/gastroenterology if 1:
- Evidence of advanced liver disease (thrombocytopenia, hypoalbuminemia, elevated INR, ascites)
- FIB-4 score suggesting advanced fibrosis
- Persistently elevated liver enzymes despite negative extended workup and no NAFLD risk factors
- Fibroscan/elastography reading >16 kPa (if available)
The best diagnostic strategy combines multiple laboratory markers with clinical context rather than relying on any single test, as no marker alone reliably identifies early alcohol-related liver injury 4.